ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Brain Cancer
Glioma
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Los Angeles, CA, USA:

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...

Active, not recruiting
Glioblastoma
Drug: Temozolomide
Biological: INO-5401

Phase 1, Phase 2

Inovio Pharmaceuticals
Inovio Pharmaceuticals

Duarte, California, United States and 20 other locations

A Phase 1b/2, Multicenter, Open-Label Study of ACP-196 in Subjects with Recurrent Glioblastoma Multiforme (GBM)...

Active, not recruiting
Glioblastoma Multiforme
Drug: ACP-196

Phase 1, Phase 2

Acerta Pharma
Acerta Pharma

Los Angeles, California, United States and 6 other locations

This is a single-arm, open-label phase II clinical trial in which approximately 55 patients with newly diagnosed glioblastoma (GBM)...

Active, not recruiting
Newly Diagnosed Glioblastoma
Biological: AV-GBM-1

Phase 2

AIVITA Biomedical

Santa Monica, California, United States and 7 other locations

The primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM...

Active, not recruiting
Glioblastoma
Glioblastoma Multiforme
Drug: Dendritic cell immunotherapy

Phase 3

Northwest Biotherapeutics
Northwest Biotherapeutics

Los Angeles, California, United States and 85 other locations

In summary, standard of care postoperative chemoradiation for patients with newly diagnosed GBM does not routinely provide durable local con...

Enrolling
Glioblastoma
Device: Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

Phase 4

GT Medical Technologies

Los Angeles, California, United States and 10 other locations

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....

Enrolling
Glioblastoma
Drug: Temozolomide
Radiation: Radiation

Phase 2, Phase 3

Global Coalition for Adaptive Research

Los Angeles, California, United States and 61 other locations

therapy alone as a treatment for newly diagnosed MGMT unmethylated glioblastoma patients. The patients' own cancer cells collected after sur...

Enrolling
Glioblastoma Multiforme of Brain
Biological: TVI-Brain-1
Procedure: Standard of Care

Phase 2, Phase 3

TVAX Biomedical

Los Angeles, California, United States and 4 other locations

with ipilimumab and surgery when used in the treatment of recurrent glioblastoma.The names of the study drugs involved in this study are:* N...

Active, not recruiting
Glioblastoma
Glioblastoma Multiforme
Drug: Nivolumab-Placebo
Drug: Nivolumab

Phase 1

Patrick Wen, MD

Los Angeles, California, United States and 3 other locations

This is an open-label, monotherapy study of pemigatinib in participants with recurrent glioblastoma (GBM) or other recurrent glioma...

Active, not recruiting
Glioblastoma
Adult-type Diffuse Gliomas
Drug: Pemigatinib

Phase 2

Incyte
Incyte

Los Angeles, California, United States and 80 other locations

as a monotherapy in participants with newly diagnosed or recurrent epidermal growth factor receptor variant III (EGFRvIII)-positive glioblastoma...

Active, not recruiting
Glioblastoma
Drug: RO7428731

Phase 1

Roche
Roche

Los Angeles, California, United States and 10 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems